Watchlist

Watchlist
Achillion Pharmaceuticals, Inc. (ACHN)
Achillion Pharmaceuticals, Inc. (ACHN)
Akari's Coversin successful in mid-stage PNH study
A Phase 2 clinical trial, COBALT , assessing Akari Therapeutics' (NASDAQ: AKTX ) lead candidate Coversin in patients with paroxysmal nocturnal hemoglobinuria (PNH) met the primary endpoint of a statistically significant reduction in LDH (lactate dehydrogenase) to within 1.8x the upper lim…
After Hours Gainers / Losers
Top gainers: CYTK +3.9% . PAA +3.7% . SOGO +1.7% . REDU +1.2% . ACHN +0.9% . More news on: Cytokinetics, Incorporated, Plains All American Pipeline, L.P., Sogou, Stocks on the move, Read more …
Premarket Gainers as of 9:05 am
CADC +198% . More news on: China Advanced Construction Materials Group, Inc., SemiLEDs Corporation, Time Inc., Stocks on the move, Read more …
After Hours Gainers / Losers
Top gainers, as of 5.25 p.m.: SORL +45.2% . CARG +11.5% . WPRT +9.6% . AMRS +7.6% . SYNC +7.5% . More news on: SORL Auto Parts, Inc., CarGurus, Inc., Westport Fuel Systems, Inc., Stocks on the move, Read more …
Achillion readies sale of 18.4M-share J&J stake; shares down 9% after hours
Achillion Pharmaceuticals (NASDAQ: ACHN ) announces plans to sell 18,367,346 common shares currently owned by Johnson & Johnson Innovation-JJDC (NYSE: JNJ ), J&J's venture capital arm. More news on: Achillion Pharmaceuticals, Inc., Johnson & Johnson, Healthcare stocks news, S…
Achillion Pharmaceuticals beats by $0.04
Achillion Pharmaceuticals (NASDAQ: ACHN ): Q3 EPS of -$0.14 beats by $0.04 . Cash and equivalents of $353.5M. Press Release More news on: Achillion Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news,
Biotech Analysis Central: Daily Pharma News - October 23, 2017
Welcome to Biotech Analysis Central Daily News, a daily news report and analysis about what has happened lately in the biotech industry. Biogen Idec Expands Partnership with Eisai News: On Monday October 23, 2017 Biogen Idec ( BIIB ) and Eisai ( ESALF ) announced that they had expa…
An In-Depth Look At Alexion's Competition And Upcoming Catalysts
Alexion Pharmaceuticals, Inc. ( ALXN ) is a biopharmaceutical company with three marketed drugs, a promising pipeline member in ALXN1210, and a market cap of over $31 billion. ALXNs major source of revenue, however, a drug called eculizumab (marketed as Soliris), may face competition i…
Achillion Is Crushed As Johnson & Johnson Heads For The Exit
Recently, Achillion Pharmaceuticals ( ACHN ) fell by 22% after the company announced that Johnson & Johnson ( JNJ ) would terminate its partnership with the company. I believe that there is further pain ahead for Achillion. It is because the Hepatitis C market is shrinking. Especially, w…
Midday Gainers / Losers
Gainers: MRNS +45% . TAHO +39% . MARK +24% . HRTG +23% . TEVA +22% . GDS +20% . HCI +17% . IDRA +17% . UVE +15% . AKTX +15% . More news on: Marinus Pharmaceuticals, Tahoe Resources Inc., Remark Media, Inc., Stocks on the move, Read more …
Midday Gainers / Losers
Gainers: MRNS +45% . TAHO +39% . MARK +24% . HRTG +23% . TEVA +22% . GDS +20% . HCI +17% . IDRA +17% . UVE +15% . AKTX +15% . More news on: Marinus Pharmaceuticals, Tahoe Resources Inc., Remark Media, Inc., Stocks on the move, Read more …
Achillion Pharmaceuticals, Inc. (ACHN)
Achillion Pharmaceuticals, Inc. (ACHN)